Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Comment by CerealKilleron Dec 22, 2020 8:17pm
148 Views
Post# 32166576

RE:RE:RE:32 testing sites up and running now. Here is the list

RE:RE:RE:32 testing sites up and running now. Here is the list
Jasper66 wrote: Copied from Medivolve twitter. Someone has done the math that out price should be .74 right now. This is @ 31 operational sites! $6mil generated per month * 55% EBITA = $3.3 mil $3.3 x 12 months = $39.6 mil (US) $39.6 mil(US)/ yr @$ 1.39 exchange = $51.09 mil (CA) $51.09 / 149 million shares outstanding = 0.343 EBIDTA/current share price of .255 / .343 = 0.74 PE ratio.


That's P.E., not price. Not the same thing (it actually means the share price should be significantly higher, so your mistake in interpreting this is a good one).
<< Previous
Bullboard Posts
Next >>